Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Gaudi Clinical develops KiOSK, a compact cell culture device that enables regenerative medicine procedures to be performed at clinical sites rather than centralized facilities. The company provides infrastructure and support for implementing regenerative medicine in healthcare institutions.
3 investors
Ai-BrainScience Inc. is a Japanese company holding a Type 2 medical device manufacturing and sales license. The company is registered as a medical device business, indicating a focus on medical technology and brain-related diagnostics.
3 investors
StemRIM is a biopharmaceutical company developing regenerative medicine therapies. It is listed on the Tokyo Stock Exchange Growth Market (ticker 4599).
3 investors
Enu Pharma (ι εγγ‘γΌγ) is a biotech startup developing antibody drugs with high selectivity based on a glycopeptide-targeting method discovered at Hokkaido University. The company aims to create new drug targets and therapies for patients with various diseases.
3 investors
TwelveStone Health Partners operates infusion centers providing chronic disease management and medication infusion services for complex conditions including multiple sclerosis, rheumatoid arthritis, and immunodeficiency disorders across the southeastern United States.
2 investors
270Surgical develops the SurroundScope, a surgical visualization device for minimally invasive surgery that offers wide-angle viewing along with fog-free and see-through-smoke capabilities. The company targets surgeons and operating rooms in the medical device/endoscopy field.
2 investors
FitXpress uses AI-powered computer vision to estimate body weight from images, enabling verification of self-reported data for BMI calculations in healthcare and wellness applications. The service is designed for healthcare providers and wellness programs requiring accurate biometric validation.
2 investors
3Dnamics engineers 3D organoid models from human stem cells to develop therapeutics for neurological diseases including Alzheimer's and Parkinson's. The company serves pharmaceutical and biotech research sectors developing novel treatments.
2 investors
4TEEN4 Pharmaceuticals develops invobenitug (procizumab), a humanized monoclonal antibody that neutralizes circulating Dipeptidyl Peptidase 3 (cDPP3) to reverse life-threatening shock and restore organ function. The company uses a biomarker-driven approach for critical care patients, with a clinical program focused on cardiogenic shock.
2 investors
A-wave develops medical devices and related software/hardware products for healthcare applications. The company was founded by healthcare professionals with Stanford Biodesign training and conducts research in medical device innovation.
2 investors
ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer. Spun out of Dalhousie University, it serves interventional oncology and radiology applications.
2 investors
ABL Bio develops biotherapeutic drugs using dual antibody platform technology for immunotherapy cancer treatments and degenerative neurological diseases. The company is a South Korea-based biotech research firm with proprietary platforms designed to treat intractable diseases.
2 investors
Able Innovations builds the ALTA Platform, a device that lets a single caregiver transfer patients at the push of a button to reduce physical strain and protect patient skin and tissue. The product targets healthcare providers and their patient-handling workflows.
2 investors
Abselion develops measurement tools and a platform combining hardware, purpose-built assay formats, and software for biological measurements such as protein quantification. It serves scientists and researchers across life sciences, biotech, and therapeutic development.
2 investors
Acarix provides diagnostic systems and supports investigator-initiated clinical trials and research projects to advance medical knowledge in cardiovascular disease assessment.
2 investors
Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications. The company designs and manufactures its medical devices for clinical use in the United States.
2 investors
Acousia develops small molecule drug candidates with a dual mode of action to enhance and preserve natural hearing in patients with sensorineural hearing loss (SNHL), targeting indications such as age-related hearing loss, cisplatin-induced and aminoglycoside ototoxicity, and cochlear implant surgery. Its lead candidate ACOU085 entered a first-in-human clinical study in age-related hearing loss in 2022.
2 investors
Acoustica.bio develops acoustophoretic technology and microgel suspension formulations that concentrate biologic drugs (such as monoclonal antibodies) to ultra-high concentrations exceeding 500 mg/mL for small-volume subcutaneous injection. It serves drug developers, aiming to convert hospital-based intravenous therapies into patient-friendly at-home injections in the biotech/drug delivery space.
2 investors
ACT Genomics is a cancer genomics company that provides genomic testing solutions to support personalized cancer care and precision medicine for patients and clinicians. Founded in 2014 as a member of the Delta Group, it focuses on the Taiwanese and broader Asian markets.
2 investors
Active Needle Technology develops active (vibrating) needle technology to improve ultrasound-guided needle interventional procedures. The company operates in the medical device sector, focusing on ultrasound devices and piezoelectric materials.
2 investors
AcuSurgical develops Luca, a tele-operated bi-manual robotic platform that assists ophthalmic surgeons in complex vitreoretinal procedures such as retinal detachment repair and macular disease treatment. The platform combines micro-precision robotics with intelligent software to improve accuracy and stability in retinal surgery.
2 investors
Adamant Health develops an AI-powered technology that uses surface electromyography (EMG) and kinematic measurements to track the visible and hidden motor symptoms of Parkinson's disease. It serves clinicians and patients by providing detailed symptom data to support personalized, continuously optimized treatment decisions.
2 investors
ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology. It operates in the biotech and pharmaceutical industry.
2 investors
2 investors